SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-060531
Filing Date
2019-11-06
Accepted
2019-11-06 16:30:31
Documents
55
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20190930x10q924475.htm   iXBRL 10-Q 1311265
2 EX-31.1 ex-31d1.htm EX-31.1 12593
3 EX-31.2 ex-31d2.htm EX-31.2 12647
4 EX-32.1 ex-32d1.htm EX-32.1 10157
  Complete submission text file 0001104659-19-060531.txt   5426755

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA espr-20190930.xsd EX-101.SCH 42548
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE espr-20190930_cal.xml EX-101.CAL 47289
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE espr-20190930_def.xml EX-101.DEF 143452
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20190930_lab.xml EX-101.LAB 430574
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20190930_pre.xml EX-101.PRE 277631
39 EXTRACTED XBRL INSTANCE DOCUMENT espr-20190930x10q924475_htm.xml XML 915580
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 191196756
SIC: 2834 Pharmaceutical Preparations